Skylight Health Group Posts Loss In Fiscal 2020; Shares Plunge 14%

Skylight Health Group shares fell more than 14% in early trading on Tuesday after the company reported fourth quarter and full-year 2020 results.

Don't Miss Our Christmas Offers:

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter

Skylight Health’s (SHG) revenue came in at $3.2 million for 4Q 2020, compared to $3.1 million for 4Q 2019. For the full year, revenue was $13.1 million, a slight drop from $13.4 million in 2019.

Net loss for the year ended December 31, 2020 came in at $9.4 million, an improvement compared to the net loss of $11 million posted in 2019. Adjusted EBITDA was a loss of $1.8 million, versus a loss of $2.7 million in 2019.

Skylight’s Co-founder and CEO Prad Sekar said, “We added 6 clinics, strengthened our leadership team, transformed our balance sheet, and made great strides toward transforming our company into a leading multi-state primary care business. We expect to see tremendous growth looking forward as we continue our profitable transition to value-based care across our platform.”

The multi-state primary care management group forecasts revenue of $40 million in 2021. (See Skylight Health Group stock analysis on TipRanks)

Two weeks ago, Echelon Wealth Partners analyst Rob Goff reiterated a Buy rating on the stock with a C$2.35 price target (132% upside potential).

Goff stated, “We view Skylight as a compelling investment leveraged to its ability to add shareholder value through organic and acquisition-driven growth as a US health clinic consolidator. We believe current healthcare needs together with provider challenges in a fragmented industry present the opportunity for significant and sustained shareholder value creation.”

Overall, the consensus is that SHG is a Strong Buy, based on 3 Buys. The average analyst price target of C$2.23 implies upside potential of about 121% to current levels. Shares have plunged by almost 30% over the last year.